top of page

The new way for early detection


Women Health First

At Nevia, we are focused on women's health.

Our mission is to use innovative technologies to provide early detection of diseases through vaginal secretions analysis, enabled by Nevia's Machine Learning Platform.

We believe in empowering women to take control of their health by providing them with the tools they need to live a healthy life. Our team is made up of passionate individuals with diverse backgrounds in healthcare, technology, and business.

Together, we are working towards a future where women's health is a top priority.

First indication: Ovarian Cancer

Ovarian cancer is also called “the silent killer".

More than 310,000 cases are diagnosed every year worldwide, and 75% of patients are diagnosed at late stages,  resulting in less than 30% survival rates.

Therefore, there is a growing demand for early-diagnosis solutions.

Nevia's platform will save lives of women around the world by enabling early detection.


Simple swab

Nevia Database

Machine learning algorithms

Test score




Development Stage

Nevia 001

Nevia 002

Nevia 003

Ovarian Cancer


Stealth mode


Clinical POC

FDA Aprroval

Why us

HLTH Diverse founders

Israeli femtech innovation leadership award

First Place Pitch Competition

Top 20 most promising companies

bottom of page